IOL Chemicals zooms on completing ANVISA GMP audit of 10 manufacturing units without any observation
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
IOL Chemicals and Pharmaceuticals is currently trading at Rs. 408.10, up by 46.60 points or 12.89% from its previous closing of Rs. 361.50 on the BSE.
The scrip opened at Rs. 369.00 and has touched a high and low of Rs. 412.30 and Rs. 369.00 respectively. So far 180405 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 535.60 on 15-Sep-2023 and a 52 week low of Rs. 272.20 on 29-Mar-2023.
Last one week high and low of the scrip stood at Rs. 412.30 and Rs. 350.30 respectively. The current market cap of the company is Rs. 2371.12 crore.
The promoters holding in the company stood at 48.19%, while Institutions and Non-Institutions held 2.54% and 49.27% respectively.
IOL Chemicals and Pharmaceuticals has successfully completed the Brazilian Health Regulatory Agency (ANVISA) GMP audit of all the 10 APIs manufacturing Units situated at Barnala, Punjab without any observation. The inspection was conducted from March 11, 2024 to March 15, 2024.
IOL Chemicals and Pharmaceuticals (IOLCP) is a leading organic chemicals manufacturers and suppliers.
